Jamie Chang, M.D.
Jamie Chang, M.D.
Melding clinical pragmatism with scientific rigor to better plan and conduct high-quality clinical trials, Dr. Jamison Chang is a board-certified internist with over 15 years of clinical experience. While his experience includes a broad range of disease entities (in both ambulatory and hospital settings), a significant portion of Dr. Chang’s clinical practice has been focused on the diagnosis and treatment of pulmonary disease.
Over the course of his clinical career, Dr. Chang has diagnosed and treated patients with numerous pulmonary conditions including asthma, emphysema and chronic bronchitis as well as cystic fibrosis lung disease. In addition, Dr. Chang has co-managed patients with pulmonary hypertension as well as a variety of interstitial lung disease. Dr. Chang’s collective experience in pulmonary disease has allowed him to more keenly understand the unmet needs in this therapeutic area and help sponsors design development programs around the specific needs of their target population.
Upon completion of his residency and chief residency at the University of North Carolina Chapel Hill, Dr. Chang obtained additional training in nephrology. He also obtained a master’s degree in clinical research (MS-CR) during the course of his renal fellowship, which allows him to utilize his clinical knowledge to better design and execute clinical trials; increasing the probability that sponsors may achieve their goals in their development programs.
Why pulmonary disease?
“Pollution and a changing environment have been linked to an increasing prevalence of pulmonary disease globally. Along with this increase in pulmonary disease prevalence, we are also seeing associated morbidity and mortality. I am eager to help develop therapies for pulmonary disease that may lessen this burden.”
This is what drives Dr. Chang:
“I’m actually driven by the need to help others. So when I realized that there were still a significant amount of unmet needs across many disease areas, given my clinical experience … I felt the need to share this knowledge and help develop therapies that would bring meaningful benefits to these patients.”